Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case Study

Cells Tissues Organs - Tập 193 Số 1-2 - Trang 23-40 - 2011
Honor J. Hugo1, Maria I. Kokkinos2, Tony Blick1, M. Leigh Ackland3, Erik W. Thompson1, Donald F. Newgreen4
1St. Vincent's Institute of Medical Research
2Pregnancy Research Centre, Department of Perinatal Medicine, and
3Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, and
4Embryology Laboratory, Murdoch Children’s Research Institute, Royal Children’s Hospital,

Tóm tắt

Epithelial-mesenchymal transition (EMT) is a feature of migratory cellular processes in all stages of life, including embryonic development and wound healing. Importantly, EMT features cluster with disease states such as chronic fibrosis and cancer. The dissolution of the E-cadherin-mediated adherens junction (AJ) is a key preliminary step in EMT and may occur early or late in the growing epithelial tumour. This is a first step for tumour cells towards stromal invasion, intravasation, extravasation and distant metastasis. The AJ may be inactivated in EMT by directed E-cadherin cleavage; however, it is increasingly evident that the majority of AJ changes are transcriptional and mediated by an expanding group of transcription factors acting directly or indirectly to repress E-cadherin expression. A review of the current literature has revealed that these factors may regulate each other in a hierarchical pattern where Snail1 (formerly Snail) and Snail2 (formerly Slug) are initially induced, leading to the activation of Zeb family members, TCF3, TCF4, Twist, Goosecoid and FOXC2. Within this general pathway, many inter-regulatory relationships have been defined which may be important in maintaining the EMT phenotype. This may be important given the short half-life of Snail1 protein. We have investigated these inter-regulatory relationships in the mesenchymal breast carcinoma cell line PMC42 (also known as PMC42ET) and its epithelial derivative, PMC42LA. This review also discusses several newly described regulators of E-cadherin repressors including oestrogen receptor-α and new discoveries in hypoxia- and growth factor-induced EMT. Finally, we evaluated how these findings may influence approaches to current cancer treatment.

Từ khóa


Tài liệu tham khảo

10.1006%2Fexcr.2000.5106

10.1290%2F1543-706X%282003%29039%3C0428%3AEMIFOO%3E2.0.CO%3B2

10.1152%2Fajpcell.00478.2005

10.1038%2Fsj.onc.1210508

10.1016%2Fj.febslet.2007.03.026

10.1586%2Fera.09.105

10.1073%2Fpnas.96.11.6249

10.1016%2Fj.bbrc.2009.04.051

10.1038%2F35000034

10.1101%2Fgad.455708

10.1016%2Fj.ygyno.2009.08.009

10.1038%2Fsj.onc.1205416

10.1007%2Fs10585-008-9170-6

10.1242%2Fjcs.00224

10.1038%2Fsj.emboj.7601421

10.2174%2F187152006777698169

10.1159%2F000084509

10.1016%2FS0140-6736%2802%2911199-8

10.1038%2Fembor.2008.74

10.1084%2Fjem.10.3.283

10.1016%2Fj.tcb.2008.05.005

10.1038%2F35000025

10.1073%2Fpnas.0903033106

10.1002%2Fpath.2138

10.1038%2Fsj.bjc.6605486

10.1038%2Fsj.onc.1204505

10.1158%2F0008-5472.CAN-07-5067

10.1158%2F0008-5472.CAN-06-0410

10.1152%2Fajplung.00197.2007

10.1038%2Fsj.onc.1209808

10.1016%2Fj.biocel.2008.09.018

10.1038%2Fsj.bjc.6604794

10.1023%2FB%3AJOMG.0000037161.91969.de

10.1158%2F1078-0432.CCR-06-0478

10.1016%2FS1097-2765%2801%2900260-X

10.1186%2F1471-2121-10-94

10.1210%2Fme.2007-0293

10.1158%2F0008-5472.CAN-08-4135

10.1016%2Fj.ygyno.2006.04.023

10.1073%2Fpnas.0700104104

10.1091%2Fmbc.E08-10-1076

10.1038%2Fsj.onc.1208429

10.1002%2Fcncr.20946

10.1038%2Fsj.onc.1208891

10.1371%2Fjournal.pone.0005595

10.1016%2Fj.canlet.2009.02.042

10.1016%2FS0092-8674%2803%2900234-4

10.1210%2Fme.2004-0258

10.2174%2F138945010790980385

10.1016%2Fj.molmed.2008.03.004

10.1080%2F07357900701226974

10.4161%2Fcc.7.20.6851

10.1074%2Fjbc.M206400200

10.1016%2Fj.jsbmb.2006.09.025

10.1016%2Fj.cell.2009.06.034

10.1158%2F0008-5472.CAN-06-3895

10.1038%2Fki.2009.222

10.1038%2Fonc.2009.397

10.1073%2Fpnas.0608636103

10.1159%2F000147748

10.1016%2FS0378-1119%2800%2900371-1

10.1007%2Fs10911-009-9110-3

10.1158%2F0008-5472.CAN-07-1371

10.1002%2Fjcp.21223

10.1186%2F1471-2407-9-235

10.1016%2FS0959-437X%2802%2900320-9

10.3816%2FCBC.2008.n.025

10.1016%2Fj.yexcr.2007.04.001

10.1038%2Fsj.onc.1210546

10.1128%2FMCB.24.17.7559-7566.2004

10.1093%2Fcarcin%2Fbgp048

10.1016%2Fj.humpath.2005.02.002

10.1016%2Fj.ccr.2009.01.023

10.1002%2Fstem.154

10.1093%2Fcarcin%2Fbgp140

10.1681%2FASN.2006030236

10.1002%2Femmm.200900043

10.1016%2FS1535-6108%2803%2900304-0

10.1038%2Fsj.bjc.6605369

10.1038%2Fnature06174

10.1016%2Fj.cell.2008.03.027

10.1073%2Fpnas.0703900104

10.1002%2Fjcb.22185

10.1245%2FASO.2005.04.010

10.1002%2Fdvdy.21685

10.1091%2Fmbc.E07-05-0406

10.2183%2Fpjab.85.314

10.1016%2Fj.ccr.2005.07.009

10.1158%2F0008-5472.CAN-06-0479

10.4161%2Fcc.5.22.3502

10.1073%2Fpnas.0602234103

10.1021%2Fla904678p

10.1093%2Fjnci%2Fdjq016

10.1126%2Fscience.1094291

10.1038%2Fnrm757

10.1073%2Fpnas.0603090103

10.1038%2Fnm1095

10.1210%2Fme.2007-0512

10.1016%2Fj.canlet.2006.12.014

10.1242%2Fjcs.01145

10.1038%2Fnrc2131

10.1074%2Fjbc.M211304200

10.1093%2Fnar%2Fgkl141

10.1002%2Fijc.22083

10.1074%2Fjbc.M100827200

10.1016%2Fj.jsbmb.2006.09.039

10.1038%2Fnrc2620

10.1016%2Fj.biocel.2007.03.002

10.1093%2Fnar%2F17.4.1619

10.1242%2Fdev.011296

10.1242%2Fdev.02297

10.1038%2Fnrm2428

10.1007%2Fs00428-009-0866-z

10.1016%2Fj.ydbio.2006.10.017

10.1242%2Fjcs.028241

10.1053%2Fj.gastro.2006.06.016

10.1158%2F0008-5472.CAN-07-5682

10.1158%2F0008-5472.CAN-05-2881

10.1159%2F000101310

10.1038%2Fki.2009.62

10.1016%2Fj.cell.2009.11.007

10.1038%2Fnrm1835

10.1016%2Fj.canlet.2008.12.026

10.1007%2Fs10585-008-9233-8

10.1158%2F0008-5472.CAN-09-1618

10.1074%2Fjbc.M509731200

10.1016%2Fj.cell.2009.03.047

10.1101%2Fgad.294104

10.1016%2Fj.canlet.2009.09.017

10.1016%2Fj.bbrc.2007.11.151

10.1245%2Fs10434-009-0480-y

10.1016%2Fj.yexcr.2008.05.004

10.1038%2Fsj.onc.1209796

10.1158%2F0008-5472.CAN-06-4729

10.1126%2Fscience.1840704

10.1016%2Fj.ccr.2009.03.016

10.1038%2Fsj.onc.1207003

10.1083%2Fjcb.200705035

10.1158%2F0008-5472.CAN-05-3086

10.1016%2Fj.cell.2004.06.006

10.1016%2Fj.devcel.2008.05.009

10.1042%2FBJ20080328

10.1038%2Fonc.2009.433

10.1016%2FS1368-8375%2800%2900059-2

10.1101%2Fgad.1809309

10.1016%2Fj.ydbio.2009.04.016

10.1016%2FS1097-2765%2803%2900179-5

10.1038%2Fncb1173